“SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND SAFETY OF SUBCUTANEOUS SEMAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY”, YHCĐ, vol. 67, no. CĐ8-NCKH, July 2026, doi: 10.52163/yhc.v67iCD8.5720.